T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| 1 |
Rivian
RIVN
|
+$16.1B |
| 2 |
Apple
AAPL
|
+$6.15B |
| 3 |
NVIDIA
NVDA
|
+$5.7B |
| 4 |
Tesla
TSLA
|
+$4.7B |
| 5 |
Microsoft
MSFT
|
+$2.23B |
Top Sells
| 1 |
Visa
V
|
+$4.3B |
| 2 |
Meta Platforms (Facebook)
META
|
+$3.34B |
| 3 |
Morgan Stanley
MS
|
+$2.78B |
| 4 |
Global Payments
GPN
|
+$2.39B |
| 5 |
PayPal
PYPL
|
+$1.74B |
Sector Composition
| 1 | Technology | 27.48% |
| 2 | Healthcare | 16.09% |
| 3 | Consumer Discretionary | 15.75% |
| 4 | Communication Services | 12.37% |
| 5 | Financials | 10.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1001
Kearny Financial
KRNY
$414M
| $50.7M | ﹤0.01% |
3,827,752
-1,434
| -0% | -$19K |
|
1002
Immuneering
IMRX
$334M
| $50.7M | ﹤0.01% |
3,188,505
+74,480
| +2% | +$1.18M |
|
|
ABMD
1003
DELISTED
Abiomed Inc
ABMD
| $50.7M | ﹤0.01% |
141,024
-442
| -0.3% | -$159K |
|
1004
Telephone and Data Systems
TDS
$4.52B
| $50.3M | ﹤0.01% |
2,494,802
-775,318
| -24% | -$15.6M |
|
1005
Synaptics
SYNA
$2.74B
| $50.3M | ﹤0.01% |
173,604
+157,523
| +980% | +$45.6M |
|
1006
Marqeta
MQ
$2.63B
| $50.2M | ﹤0.01% |
+2,923,199
| New | +$50.2M |
|
|
PRFT
1007
DELISTED
Perficient Inc
PRFT
| $49.9M | ﹤0.01% |
385,776
+25
| +0% | +$3.23K |
|
|
HCCI
1008
DELISTED
Heritage-Crystal Clean, Inc.
HCCI
| $49.7M | ﹤0.01% |
1,552,185
-68,825
| -4% | -$2.2M |
|
|
FRGI
1009
DELISTED
Fiesta Restaurant Group, Inc.
FRGI
| $49.6M | ﹤0.01% |
4,500,831
-162,075
| -3% | -$1.78M |
|
1010
Blackstone
BX
$142B
| $49.5M | ﹤0.01% |
382,774
+5,020
| +1% | +$650K |
|
1011
Brown-Forman Class B
BF.B
$12.9B
| $49.3M | ﹤0.01% |
677,117
-14,520
| -2% | -$1.06M |
|
|
CHCT
1012
Community Healthcare Trust
CHCT
$446M
| $49.1M | ﹤0.01% |
1,039,016
+65,361
| +7% | +$3.09M |
|
|
REVHU
1013
DELISTED
Revolution Healthcare Acquisition Corp. SAIL Units
REVHU
| $49.1M | ﹤0.01% |
4,982,268
-77,009
| -2% | -$759K |
|
1014
Arista Networks
ANET
$178B
| $48.8M | ﹤0.01% |
1,359,008
-832
| -0.1% | -$29.9K |
|
1015
ACI Worldwide
ACIW
$5.21B
| $48.7M | ﹤0.01% |
1,402,424
-55,153
| -4% | -$1.91M |
|
1016
Innovative Industrial Properties
IIPR
$1.61B
| $48.6M | ﹤0.01% |
184,971
+23,732
| +15% | +$6.24M |
|
1017
Allogene Therapeutics
ALLO
$253M
| $48.5M | ﹤0.01% |
3,251,528
-1,087,463
| -25% | -$16.2M |
|
|
BCYC
1018
Bicycle Therapeutics
BCYC
$477M
| $48.5M | ﹤0.01% |
+796,014
| New | +$48.5M |
|
1019
Expeditors International
EXPD
$16.8B
| $48.3M | ﹤0.01% |
359,968
-9,335
| -3% | -$1.25M |
|
1020
Nasdaq
NDAQ
$54.2B
| $48.3M | ﹤0.01% |
689,904
-15,192
| -2% | -$1.06M |
|
1021
Phillips 66
PSX
$53B
| $48.3M | ﹤0.01% |
665,966
-23,943
| -3% | -$1.73M |
|
1022
MeiraGTx Holdings
MGTX
$602M
| $48M | ﹤0.01% |
2,020,745
+17,725
| +0.9% | +$421K |
|
1023
Williams Companies
WMB
$72B
| $47.9M | ﹤0.01% |
1,839,897
-69,764
| -4% | -$1.82M |
|
1024
Rocket Pharmaceuticals
RCKT
$340M
| $47.9M | ﹤0.01% |
2,192,894
-691,532
| -24% | -$15.1M |
|
1025
Denny's
DENN
$264M
| $47.6M | ﹤0.01% |
2,977,847
-162,679
| -5% | -$2.6M |
|